Sleep aids is expected to see value sales at constant 2017 prices decline throughout the forecast period. The category will continue to suffer from the fact that there has long been a stigma attached to psychoactive drugs and other types of medications related to psychological disorders in Japan. This stigma discourages many consumers from using sleep aids, despite the fact that most of these products only have a calming or relaxing effect that makes it easier to fall asleep.BRBREuromonitor International's Sleep Aids in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.BRBRData coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.BRBRWhy buy this report?ULLI Get a detailed picture of the Sleep Aids market;/LILI Pinpoint growth sectors and identify factors driving change;/LILI Understand the competitive environment, the market’s major players and leading brands;/LILI Use five-year forecasts to assess how the market is predicted to develop./LI/ULBRBREuromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.